Featured Press Releases

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent

Innocan Pharma submits Investigational New Animal Drug application to FDA

Innocan Pharma submits Investigational New Animal Drug application to FDA's Veterinary Center.

  • 26 Jul 2024

Innocan Pharma Corporation a pioneer in the pharmaceutical and biotechnology industries, is...

Persist AI and Nivagen partner to develop AI-driven manufacturing for long-acting injectables

Persist AI and Nivagen partner to develop AI-driven manufacturing for long-acting injectables

IRBM Expands Functional Genomics Platform for Early Drug Discovery

IRBM Expands Functional Genomics Platform for Early Drug Discovery

Boehringer Ingelheim launches swine vaccine with advanced protection against Porcine Circovirus Type 2 in the U.S

Boehringer Ingelheim launches swine vaccine with advanced protection against Porcine Circovirus Type 2 in the U.S

ulrich medical USA® Expands Commitment to Evidence-Based Spine Innovation; Appoints Alissa Calaway, RN, MSN as Director of U.S. Clinical Affairs

ulrich medical USA® Expands Commitment to Evidence-Based Spine Innovation; Appoints Alissa Calaway, RN, MSN as Director of U.S. Clinical Affairs

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

Kerri McCullough Wood Named Chief Commercial Officer at Avid Bioservices

  • Avid Bioservices
  • 12 May 2026
BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

BIZENGRI® (Zenocutuzumab-zbco) Wins FDA Approval for NRG1 Fusion-Positive Cholangiocarcinoma, Says Partner Therapeutics

  • Partner Therapeutics, Inc.
  • 12 May 2026
Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

Miach Orthopaedics Appoints Jamal Rushdy as President & CEO

  • Miach Orthopaedics, Inc.
  • 11 May 2026
Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

Avenacy Announces U.S. Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection

  • Avenacy
  • 11 May 2026
New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

New Study Suggests 5-MTHF as Effective Alternative to Folic Acid in Later Pregnancy

  • Ritual
  • 07 May 2026
Viralgen Teams with Elaaj Bio to Advance CDKL5 Deficiency Gene Therapy

Viralgen Teams with Elaaj Bio to Advance CDKL5 Deficiency Gene Therapy

  • Viralgen
  • 07 May 2026
The Digital Pharma Advances Conference 2026

Most Popular
May   2026
M T W T F S S
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.